Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 11Uterine Cervical Dysplasia 4Papillomavirus Infections 2Ovarian Neoplasms 2Neoplasms 2Uterine Neoplasms 1Precancerous Conditions 1Ovarian Diseases 1HIV Infections 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

Carboplatin 156Paclitaxel 154Bevacizumab 96Cyclophosphamide 61Gemcitabine 46olaparib 45Cisplatin 45Topotecan 44niraparib 40liposomal doxorubicin 40pembrolizumab 38Surveys and Questionnaires 33Filgrastim 31Hyperthermic Intraperitoneal Chemotherapy 29Docetaxel 27Taxes 25Blood Specimen Collection 24fludarabine 23Drug Therapy 23Cytoreduction Surgical Procedures 23Peripheral Blood Stem Cell Transplantation 21Etoposide 21Doxorubicin 21Magnetic Resonance Spectroscopy 20durvalumab 17Specimen Handling 17Albumin-Bound Paclitaxel 17Immunoglobulin G 15Disulfides 15Letrozole 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Ovarian Neoplasms × Papanicolaou Test × Clear all
NCT04794322 2025-09-16

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Massachusetts General Hospital

Recruiting
250 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Ovarian Diseases, Ovarian Neoplasms

NCT03606486 2024-01-17

Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer

University of Washington

Phase NA Terminated
52 enrolled 6 charts
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡